Clinical Trials Logo

Filter by:
NCT ID: NCT05250817 Completed - Clinical trials for Carcinoma, Non-Small-Cell Lung

A Study of Preferences for the First-Line Treatment of Advanced/Metastatic Non-Small Cell Lung Cancer

Start date: December 9, 2021
Phase:
Study type: Observational

The purpose of this observational study is to determine participants' preferences for outcomes associated with first-line treatment of advanced/metastatic Non-Small Cell Lung Cancer (NSCLC) using a discrete-choice experiment (DCE).

NCT ID: NCT05250778 Completed - Clinical trials for Patient Satisfaction

Nudges on Hospitalist Behavior and Patient Satisfaction

Start date: April 11, 2022
Phase: N/A
Study type: Interventional

Physician behavior plays an important role on patient perception of their care team and on patient satisfaction. Though studies have attempted to impact how physicians interact with their patients through various initiatives, the effect of more subtle nudges on physician behavior have not been studies. As such, the investigators propose a randomized controlled deception trial to evaluate the impact of nudges on hospitalist behavior and patient satisfaction.

NCT ID: NCT05250102 Completed - Premature Birth Clinical Trials

Neonatal Pulse Oximetry Sensor Study

Start date: June 13, 2022
Phase: N/A
Study type: Interventional

To validate the SpO2 accuracy, bias, and precision of Medline's reprocessed pulse oximetry sensors as compared to SaO2 in arterial blood samples as assessed by CO-oximetry in neonates.

NCT ID: NCT05249621 Completed - Healthy Clinical Trials

A Randomized Phase 1 of of MZE001 in Healthy Volunteers

Start date: February 7, 2022
Phase: Phase 1
Study type: Interventional

This is a Phase 1, randomized, double-blind, placebo-controlled, single (SAD) / multiple (MAD) ascending dose and food effect study.

NCT ID: NCT05249582 Completed - Virtual Reality Clinical Trials

Virtual Reality Compared to Screen Based Engagement on Mood

Start date: January 29, 2022
Phase: N/A
Study type: Interventional

Depression has a lifetime prevalence rate of 20.6% and has one of the highest prevalence rates of mental health disorders. Major depressive disorder can lead to higher costs of living for individuals as well as a larger economic decrease associated with inability to work. Current treatment targets one of the two core symptoms of depression of decreased mood or loss of interest in activities. However, current treatment models are not enough because there are more individuals who require treatment than treatment opportunities which creates inequities of care. Digital interventions provide a unique opportunity to increase widespread accessibility of treatment at reduced and scalable costs. Virtual reality is a newer type of digital intervention that consists of providing experiences for individuals that are different from the physical environment they are currently in. Through audio and visual displays, virtual reality creates a sense of presence, or the experience of immersion, with an environment. Virtual reality has been used in a variety of clinical psychology areas such as training, assessment, and treatment of mental health disorders and other medical conditions. Despite research finding efficacy for virtual reality with anxiety and PTSD, few studies have examined the impact of virtual reality on depressive disorders and low mood. Of studies that have looked at mood changes, most studies measured indirect measures of mood such as energy levels which leads to a gap of research on the efficacy of virtual reality with low mood. The present study aims to examine if virtual reality exergames improve participant's mood and affect. Additionally, the study will determine if there are different effects of presence, depressive symptoms, and technology familiarity on mood. Furthermore, the study will examine helpfulness and satisfaction to examine usability of virtual reality as a medium for clinical intervention. Lastly, findings of this study could inform the development and efficacy of virtual reality interventions that can be used to provide more access to treatment for individuals and improve outcomes to reduce the burdens associated with depression.

NCT ID: NCT05249530 Completed - Healthy Clinical Trials

Chiropractic Force Versus Touch

FVT
Start date: September 28, 2021
Phase: N/A
Study type: Interventional

The Life University Center for Chiropractic Research is conducting a research study to better understand the physiologic and brain-based differences between the touch and force components of the chiropractic adjustment. Eligible individuals will either receive a chiropractic adjustment with force or a non-force stimulation. Individuals in the force stimulation group will receive an active spinal adjustment with a handheld instrument called an Activator. Individuals in the non-force stimulation group will have one Activator placed on the spine and another Activator clicked away from the spine. This study is not randomized. The first participant will receive an active spinal adjustment, and the second participant will receive a non-force stimulation at the same locations as the first participant. This pattern repeats until all individuals have been recruited (n=30). Outcome assessments include resting state electroencephalography (EEG), electrocardiography (ECG), and blood pressure. Outcome assessments will be captured prior to the adjustment or non-force stimulation, after the adjustment or non-force stimulation, and one week later. Individuals will also undergo a standard health history and chiropractic physical exam at the start of participation.

NCT ID: NCT05249348 Completed - Healthy Volunteers Clinical Trials

Effect of Food on PC14586 in Healthy Volunteers and the PK of PC14586 in Healthy Japanese Volunteers

Start date: December 20, 2021
Phase: Phase 1
Study type: Interventional

This is a 2-part Phase 1 cross-over study to assess the effects of food on the pharmacokinetics of PC14586 in healthy volunteers. The pharmacokinetics of PC14586 at a clinically relevant dose in Japanese participants will also be studied.

NCT ID: NCT05249257 Completed - Cellulite Clinical Trials

Durability and Safety of CCH With Two Different Injection Techniques in Cellulite With Laxity

Start date: January 25, 2022
Phase:
Study type: Observational

All participants who completed the EN3835-224 study will be invited to participate in this observational study to evaluate long term durability of response and safety.

NCT ID: NCT05249127 Completed - Clinical trials for Biochemical Recurrence of Malignant Neoplasm of Prostate

64Cu-SAR-bisPSMA for Identification of Participants With Recurrence of Prostate Cancer (COBRA)

COBRA
Start date: April 11, 2022
Phase: Phase 1/Phase 2
Study type: Interventional

The aim of this study is to determine the safety and efficacy of 64Cu-SAR-bisPSMA and determine the ability of 64Cu-SAR-bisPSMA Positron emission tomography (PET)/computed tomography (CT) to correctly detect the recurrence of prostate cancer in participants with biochemical recurrence of prostate cancer following definitive therapy.

NCT ID: NCT05248997 Completed - Clinical trials for Chronic Rhinosinusitis (CRS) With and Without Nasal Polyps

Safety and Efficacy of BHV-3000 (Rimegepant) Orally Disintegrating Tablet for the Acute Treatment of Chronic Rhinosinusitis

Start date: February 17, 2022
Phase: Phase 3
Study type: Interventional

The purpose of this study is to compare the efficacy and safety of rimegepant versus placebo in the acute treatment of chronic rhinosinusitis (CRS) with and without nasal polyps.